Manjili MH - Search Results

1

The premise of personalized immunotherapy for cancer dormancy.

Manjili MH. Manjili MH. Oncogene. 2020 May;39(22):4323-4330. doi: 10.1038/s41388-020-1295-3. Epub 2020 Apr 22. Oncogene. 2020. PMID: 32322001 Free PMC article. Review.

2

Cancer immunotherapy: stress proteins and hyperthermia.

Manjili MH, Wang XY, Park J, Macdonald IJ, Li Y, Van Schie RC, Subjeck JR. Manjili MH, et al. Int J Hyperthermia. 2002 Nov-Dec;18(6):506-20. doi: 10.1080/02656730110116696. Int J Hyperthermia. 2002. PMID: 12537751 Free article. Review.

3

Adaptive immune responses associated with breast cancer relapse.

Payne KK, Manjili MH. Payne KK, et al. Among authors: manjili mh. Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):345-50. doi: 10.1007/s00005-012-0185-y. Epub 2012 Aug 22. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22911133 Free article. Review.

4

Immunotherapy of cancer: reprogramming tumor-immune crosstalk.

Payne KK, Toor AA, Wang XY, Manjili MH. Payne KK, et al. Among authors: manjili mh. Clin Dev Immunol. 2012;2012:760965. doi: 10.1155/2012/760965. Epub 2012 Oct 11. Clin Dev Immunol. 2012. PMID: 23097673 Free PMC article. Review.

5

IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse.

Kmieciak M, Payne KK, Wang XY, Manjili MH. Kmieciak M, et al. Among authors: manjili mh. PLoS One. 2013 Dec 6;8(12):e82544. doi: 10.1371/journal.pone.0082544. eCollection 2013. PLoS One. 2013. PMID: 24324806 Free PMC article.

6

The inherent premise of immunotherapy for cancer dormancy.

Manjili MH. Manjili MH. Cancer Res. 2014 Dec 1;74(23):6745-9. doi: 10.1158/0008-5472.CAN-14-2440. Epub 2014 Nov 19. Cancer Res. 2014. PMID: 25411346 Review.

7

Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?

Manjili MH, Payne KK. Manjili MH, et al. Discov Med. 2015 Jun;19(107):427-31. Discov Med. 2015. PMID: 26175400 Free article. Review.

8

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.

Payne KK, Keim RC, Graham L, Idowu MO, Wan W, Wang XY, Toor AA, Bear HD, Manjili MH. Payne KK, et al. Among authors: manjili mh. J Leukoc Biol. 2016 Sep;100(3):625-35. doi: 10.1189/jlb.5A1215-580R. Epub 2016 Feb 29. J Leukoc Biol. 2016. PMID: 26928306 Free PMC article.

9

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.

Terracina KP, Graham LJ, Payne KK, Manjili MH, Baek A, Damle SR, Bear HD. Terracina KP, et al. Among authors: manjili mh. Cancer Immunol Immunother. 2016 Sep;65(9):1061-73. doi: 10.1007/s00262-016-1868-8. Epub 2016 Jul 14. Cancer Immunol Immunother. 2016. PMID: 27416831 Free PMC article.

10

Role of Tregs in Cancer Dormancy or Recurrence.

Manjili MH, Butler SE. Manjili MH, et al. Immunol Invest. 2016 Nov;45(8):759-766. doi: 10.1080/08820139.2016.1194428. Epub 2016 Sep 7. Immunol Invest. 2016. PMID: 27603507 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page